Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004

the NAGOYA HEART Study Group

doi:10.1016/j.jjcc.2015.01.001

Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004

the NAGOYA HEART Study Group

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	259
Number of pages	1
Journal	Journal of Cardiology
Volume	65
Issue number	3
DOIs	https://doi.org/10.1016/j.jjcc.2015.01.001
State	Published - Mar 1 2015

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jjcc.2015.01.001

Cite this

the NAGOYA HEART Study Group (2015). Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004. Journal of Cardiology, 65(3), 259. https://doi.org/10.1016/j.jjcc.2015.01.001

Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004. / the NAGOYA HEART Study Group.
In: Journal of Cardiology, Vol. 65, No. 3, 01.03.2015, p. 259.

Research output: Contribution to journal › Comment/debate › peer-review

the NAGOYA HEART Study Group 2015, 'Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004', Journal of Cardiology, vol. 65, no. 3, pp. 259. https://doi.org/10.1016/j.jjcc.2015.01.001

the NAGOYA HEART Study Group. Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004. Journal of Cardiology. 2015 Mar 1;65(3):259. doi: 10.1016/j.jjcc.2015.01.001

@article{210a08fd4a6b47069095f9bdd61ed363,

title = "Corrigendum to {"}Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance{"}, [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004",

author = "{the NAGOYA HEART Study Group} and Kunihiro Matsushita and Takashi Muramatsu and Takahisa Kondo and Kengo Maeda and Satoshi Shintani and Toyoaki Murohara",

year = "2015",

month = mar,

day = "1",

doi = "10.1016/j.jjcc.2015.01.001",

language = "English (US)",

volume = "65",

pages = "259",

journal = "Journal of Cardiology",

issn = "0914-5087",

publisher = "Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai)",

number = "3",

}

TY - JOUR

T1 - Corrigendum to "Rationale and design of the NAGOYA HEART Study

T2 - Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004

AU - the NAGOYA HEART Study Group

AU - Matsushita, Kunihiro

AU - Muramatsu, Takashi

AU - Kondo, Takahisa

AU - Maeda, Kengo

AU - Shintani, Satoshi

AU - Murohara, Toyoaki

PY - 2015/3/1

Y1 - 2015/3/1

UR - http://www.scopus.com/inward/record.url?scp=84924297455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924297455&partnerID=8YFLogxK

U2 - 10.1016/j.jjcc.2015.01.001

DO - 10.1016/j.jjcc.2015.01.001

M3 - Comment/debate

AN - SCOPUS:84924297455

SN - 0914-5087

VL - 65

SP - 259

JO - Journal of Cardiology

JF - Journal of Cardiology

IS - 3

ER -

Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance", [J. Cardiol., 56, (2010), 111-117], doi:10.1016/j.jjcc.2010.03.004

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this